Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc.'s SEC filings document financial results, operating updates, governance matters, and public-company disclosures for its beverage brand portfolio. Form 8-K reports include quarterly and annual results, guidance updates, Regulation FD disclosures, and other material events related to the company’s coconut water and better-for-you beverage operations.
Proxy materials describe annual meeting proposals, board structure, committee assignments, executive compensation, equity awards, and stockholder voting matters. Additional 8-K filings record director appointments, board retirements, officer roles, compensation arrangements, tariff-related disclosures, and the company’s capital-market reporting obligations as a Nasdaq-listed Delaware corporation.
On 30 July 2025, The Vita Coco Company, Inc. (COCO) filed a Form 8-K announcing that it has furnished (not filed) a press release containing financial results for the quarter ended 30 June 2025. The actual earnings figures are not included in the filing; they are contained in Exhibit 99.1. Accordingly, today’s 8-K serves only to formally disclose the release and provide XBRL cover-page data. No guidance revisions, strategic actions, or other material transactions are described.
Form 144 filing highlights
On 18 June 2025, an affiliate of The Vita Coco Company, Inc. (NASDAQ: COCO) filed a Form 144 with the U.S. SEC. The notice states the filer intends to sell 10,000 common shares through Morgan Stanley Smith Barney LLC at an aggregate market value of $345,900, implying a reference price near $34.59 per share. The shares were acquired the same day via the exercise of stock options and are scheduled for sale on or about 18 June 2025 on the NASDAQ.
Transaction scale
The planned disposition equals roughly 0.018 % of Vita Coco’s 56,733,572 shares outstanding, signalling a de-minimis impact on the company’s float and no dilution, as the shares are already issued. The filer reported no other sales during the prior three-month period.
Regulatory context
Form 144 is a routine notice required when company insiders or affiliates intend to sell restricted or control securities under Rule 144. By signing, the filer affirms that no non-public material adverse information is known. No additional financial or operational data were provided in the document.